ReportPoland

Poland Medical Cannabis Market Review (2025 Full Year Data & 2026-2027 Forecast)

Access, regulation and the commercial opportunity in Poland's medical market.

Poland — sizing, forecasts and regulatory outlook
Analyst-written market analysis
72+ pages · PDF + data
Published 2026

About this edition

Access, regulation and the commercial opportunity in Poland's medical market. It combines PP’s proprietary market sizing with regulatory analysis, giving investors and corporates a single, citable reference — delivered digitally, licensed for internal use, and backed by the analysts who built the numbers.

market covered

72+

pages of analysis

2026

published

Inside this edition

Contents13

Market Size & Growth Trajectory
The Telemedicine Ban: Shock & Recovery
Pricing Dynamics
Sales Revenue
Methodological Note: Volume Reporting Units
Forecast: 2026–2027
Strategic Implications
Data Sources & Methodology
5,447 kg flower dispensed in 2025 (+12% YoY) — full recovery from November 2024 telemedicine ban
Revenue fell 19% to ~€60M despite volume growth — aggressive price compression (28% decline YoY)
December 2025 volumes and prescriptions hit all-time highs — structural patient demand confirmed
84 months of pharmacy-level data (Jan 2019–Dec 2025) — longest continuous Poland dataset available
Complete shock-and-recovery cycle documented — only European market with this level of regulatory stress-test data

Who it’s for

Investors & analysts

Defensible sizing and forecasts to underwrite the thesis.

Corporate strategy & FMCG

Opportunity sizing and entry routes across key markets.

Poland Medical Cannabis Market Review (2025 Full Year Data & 2026-2027 Forecast)

About this edition

Inside this edition

Who it’s for

More from the library